Vaccination

Study uncovers reasons Americans did not get booster vaccines

In September 2022, new bivalent COVID-19 boosters became available in the United States, but less than 20% of the eligible population ultimately received one. A new study led by researchers in the University of Arizona Mel ...

Diseases, Conditions, Syndromes

Trivalent vaccine candidate fights measles, mumps, SARS-CoV-2

Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.

Diseases, Conditions, Syndromes

New rapid electronic diagnostic test for infectious diseases

A new molecular test for bacteria and viruses, including SARS-CoV-2 has been developed by scientists at the University of Surrey, as they warn that the world needs to be prepared for the next pandemic.

Medications

Antiviral drug molnupiravir linked to SARS-CoV-2 mutations

Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town and UKHSA have uncovered a link between an antiviral drug for COVID-19 ...

page 12 from 40